Insymbiosis Overview

  • Founded
  • 2005
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 15
Employees
  • Latest Deal Type
  • Buyout/​LBO
  • Financing Rounds
  • 1

Insymbiosis General Information

Description

Owner and operator of a biotechnology company. The company operates as a contract research organization that provides pre-clinical drug discovery and development services to the biopharmaceutical industry.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Acquirer
Primary Office
  • 507 Place d'Armes
  • Suite 101
  • Montreal, Quebec H2Y 2W8
  • Canada
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Insymbiosis Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Insymbiosis‘s full profile, request access.

Request a free trial

Insymbiosis Executive Team (4)

Name Title Board Seat Contact Info
Marcel Pinchevsky Chief Operating Officer
Christina Wisemann Controller
Dean Wenham Ph.D Founder, President & Chief Executive Officer
You’re viewing 3 of 4 executive team members. Get the full list »

Insymbiosis Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial